+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

At-home Drug of Abuse Testing Market by Product, Test Type, Drug, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5716235
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The At-home Drug of Abuse Testing Market grew from USD 2.68 billion in 2023 to USD 2.88 billion in 2024. It is expected to continue growing at a CAGR of 7.25%, reaching USD 4.38 billion by 2030.

The at-home Drug of Abuse Testing market encompasses tests that individuals can use privately to detect the presence of illicit substances in their systems. These tests are often used by parents, employers, or individuals monitoring their own drug habits. Necessity arises from the increasing awareness of drug misuse and its implications on health and safety. Applications include testing for various substances such as opioids, marijuana, cocaine, and amphetamines, with end-users spanning private individuals, educational institutions, and workplaces. Market growth is driven by heightened substance abuse awareness, regulatory support, and advancements in testing technology that enhance accuracy and ease of use. The pandemic has shifted consumer preferences towards at-home solutions, creating potential opportunities in this segment. Increased legalization of cannabis, combined with societal focus on mental health and wellness, presents a crucial opportunity for market expansion by integrating substance misuse prevention into broader wellness products. However, challenges include public perception concerns surrounding privacy and the potential for false negatives or positives which can limit acceptance. Regulatory hurdles and the need for robust scientific validation also present barriers. Innovators can explore enhanced digital integration for results interpretation, smartphone connectivity for tracking, and the development of tests for new psychoactive substances. Additionally, partnerships with telemedicine services could provide comprehensive solutions encompassing testing, diagnosis, and treatment recommendations. The market is characterized by its consumer-focused nature, necessitating ongoing research into user-friendliness and education on the reliability and limitations of home tests. Companies should align with growing trends of personalization and data security to differentiate their offerings. Collaboration with advocacy groups and law enforcement could also support market penetration by reinforcing the value of personal responsibility in substance monitoring. This dynamic landscape offers significant room for innovation in product diversification and strategic alliances.

Understanding Market Dynamics in the At-home Drug of Abuse Testing Market

The At-home Drug of Abuse Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing use and production of illicit drugs
    • Government initiatives to reduce drug abuse
    • Expansion of drug production necessitates effective test measures
  • Market Restraints
    • Inability of testing products to detect small amounts of special drugs
  • Market Opportunities
    • Technological advancement and development of novel at-home drug of abuse testing devices
    • Investment in R&D activities for at-home drug of abuse testing devices
  • Market Challenges
    • Lack of awareness of at-home drug of abuse testing devices

Exploring Porter’s Five Forces for the At-home Drug of Abuse Testing Market

Porter’s Five Forces framework further strengthens the insights of the At-home Drug of Abuse Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the At-home Drug of Abuse Testing Market

External macro-environmental factors deeply influence the performance of the At-home Drug of Abuse Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the At-home Drug of Abuse Testing Market

The At-home Drug of Abuse Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the At-home Drug of Abuse Testing Market

The At-home Drug of Abuse Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the At-home Drug of Abuse Testing Market

The At-home Drug of Abuse Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the At-home Drug of Abuse Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Accuquik by AdvaCare Pharma USA, Atlas Medical GmbH, BioMerieux, Inc., Biopanda Reagents Ltd., BTNX Inc., Confirm BioSciences, Drägerwerk AG & Co. KGaA, Exploro Products, Identify Diagnostics by Medical Distribution Group, Inc., Innovatek Medical Inc., InTec Products, Inc., Laboratory Corporation of America Holdings, McKesson Medical-Surgical, MyDiagnostics by Phyteos Helath Systems Inc., myLAB Box Inc., OraSure Technologies, Inc., Phamatech Inc. by Caris Life Sciences, Psychemedics Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., UCP Biosciences Inc., Vitrosens Biotechnology, and Xiamen Boson Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the At-home Drug of Abuse Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Blood-Based Testing Kits
    • Breathalyzer Testing Kits
    • Hair-Based Testing Kits
    • Saliva-Based Testing Kits
    • Urine-Based Testing Kits
  • Test Type
    • Cups
    • Strips
  • Drug
    • Alcohol
    • Amphetamines
    • Benzodiazepines
    • Cocaine
    • Marijuana
    • Opioids
  • Distribution Channel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing use and production of illicit drugs
5.1.1.2. Government initiatives to reduce drug abuse
5.1.1.3. Expansion of drug production necessitates effective test measures
5.1.2. Restraints
5.1.2.1. Inability of testing products to detect small amounts of special drugs
5.1.3. Opportunities
5.1.3.1. Technological advancement and development of novel at-home drug of abuse testing devices
5.1.3.2. Investment in R&D activities for at-home drug of abuse testing devices
5.1.4. Challenges
5.1.4.1. Lack of awareness of at-home drug of abuse testing devices
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. At-home Drug of Abuse Testing Market, by Product
6.1. Introduction
6.2. Blood-Based Testing Kits
6.3. Breathalyzer Testing Kits
6.4. Hair-Based Testing Kits
6.5. Saliva-Based Testing Kits
6.6. Urine-Based Testing Kits
7. At-home Drug of Abuse Testing Market, by Test Type
7.1. Introduction
7.2. Cups
7.3. Strips
8. At-home Drug of Abuse Testing Market, by Drug
8.1. Introduction
8.2. Alcohol
8.3. Amphetamines
8.4. Benzodiazepines
8.5. Cocaine
8.6. Marijuana
8.7. Opioids
9. At-home Drug of Abuse Testing Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Americas At-home Drug of Abuse Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific At-home Drug of Abuse Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa At-home Drug of Abuse Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. AT-HOME DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AT-HOME DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. AT-HOME DRUG OF ABUSE TESTING MARKET DYNAMICS
TABLE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BREATHALYZER TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 42. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 46. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 64. CHINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 68. INDIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 76. JAPAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 100. THAILAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 113. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 117. EGYPT AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 121. FINLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 125. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 129. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 137. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 149. NORWAY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 153. POLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 157. QATAR AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 173. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 185. TURKEY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the At-home Drug of Abuse Testing market, which are profiled in this report, include:
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Accuquik by AdvaCare Pharma USA
  • Atlas Medical GmbH
  • BioMerieux, Inc.
  • Biopanda Reagents Ltd.
  • BTNX Inc.
  • Confirm BioSciences
  • Drägerwerk AG & Co. KGaA
  • Exploro Products
  • Identify Diagnostics by Medical Distribution Group, Inc.
  • Innovatek Medical Inc.
  • InTec Products, Inc.
  • Laboratory Corporation of America Holdings
  • McKesson Medical-Surgical
  • MyDiagnostics by Phyteos Helath Systems Inc.
  • myLAB Box Inc.
  • OraSure Technologies, Inc.
  • Phamatech Inc. by Caris Life Sciences
  • Psychemedics Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • UCP Biosciences Inc.
  • Vitrosens Biotechnology
  • Xiamen Boson Biotech Co., Ltd.

Methodology

Loading
LOADING...

Table Information